Rich Day on the Stock Market for California "Eat Me" Cancer Therapy Firm
Forty Seven went public in June 2018. Here is how its stock has performed.
Google graphic
The stock price of Forty Seven, Inc., the high-flying company with a $15 million link to the California stem cell agency, today closed nine times higher than its all-time low just last October.
The stock hit $50.00, 19 percent above its close yesterday. Its low last …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.